Gigantic Cutaneous Horn: a Clinical Case and a Literature Review
Clinical Practice
Kristupas Suslavičius
Lithuanian University of Health Sciences
Žygimantas Mačys
Vilnius University, Lithuania
Gediminas Rauba
Vilnius University, Lithuania
Published 2022-04-27
https://doi.org/10.15388/LietChirur.2022.21.56
PDF
HTML

Keywords

keratoacanthoma
skin horn
squamous cell carcinoma
keratoacanthoma treatment
keratoacanthoma diagnosis
skin horn treatment
squamous cell carcinoma treatment

How to Cite

1.
Suslavičius K, Mačys Žygimantas, Rauba G. Gigantic Cutaneous Horn: a Clinical Case and a Literature Review. LS [Internet]. 2022Apr.27 [cited 2022Aug.9];21(1):41-6. Available from: https://www.journals.vu.lt/lietuvos-chirurgija/article/view/27419

Abstract

Keratoacanthoma is a benign skin tumour caused mainly by ultraviolet A radiation. It affects 150 out of every 100 000 people worldwide. The most common location is the face, neck, and hands. Keratoacanthoma usually affects middle-aged and older men with a fair skin phenotype. More importantly, this disease may be a complication of cutaneous cornification. Keratoacanthoma is described as a circumscribed conical prominent hyperkeratotic lesion in the literature, and the main factor provoking this complication is ultraviolet radiation. Fair skin phenotype, male sex, and older age may contribute to the development of cutaneous horn disease. Another possible complication of keratoacanthoma is squamous cell carcinoma, which is defined as a malignant composed of epidermal keratinocytes skin tumour. Squamous cell carcinoma is very similar to keratoacanthoma, but is prone to metastasis and has unclear tumour borders. Ultraviolet radiation and the treatment of keratoacanthoma by using chemotherapy are some of the main provocative factors. All three of these diseases are treated surgically. The purpose of this article is to discuss the etiopathogenesis, clinic, diagnosis, treatment of kerato­acanthoma, essential complications – skin horn, squamous cell carcinoma, and a clinical case related to these diseases.

PDF
HTML
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Please read the Copyright Notice in Journal Policy

Most read articles by the same author(s)